Filing Details

Accession Number:
0000950103-21-002459
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-17 20:24:48
Reporting Period:
2021-02-12
Accepted Time:
2021-02-17 20:24:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1828182 Signify Health Inc. SGFY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653708 Kyle Bradford Armbrester C/O Signify Health, Inc.
800 Connecticut Avenue
Norwalk CT 06854
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-12 100 $1.00 0 No 4 D Direct
Class B Common Stock Acquisiton 2021-02-12 3,686,599 $0.01 3,686,599 No 4 A Direct
Class B Common Stock Acquisiton 2021-02-12 1,043,854 $0.01 1,043,854 No 4 A Indirect By KA Family Investments, LLC
Class B Common Stock Acquisiton 2021-02-12 1,260,625 $0.01 1,260,625 No 4 A Indirect By PA Family Enterprises, LLC
Class A Common Stock Acquisiton 2021-02-16 13,900 $24.00 13,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 D Direct
No 4 A Direct
No 4 A Indirect By KA Family Investments, LLC
No 4 A Indirect By PA Family Enterprises, LLC
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock LLC Units in Cure Aggregator, LLC Acquisiton 2021-02-12 2,209,940 $0.00 2,209,940 $0.00
Class A Common Stock LLC Units in Cure Aggregator, LLC Acquisiton 2021-02-12 1,476,659 $0.00 1,476,659 $0.00
Class A Common Stock LLC Units in Cure Aggregator, LLC Acquisiton 2021-02-12 1,043,854 $0.00 1,043,854 $0.00
Class A Common Stock LLC Units in Cure Aggregator, LLC Acquisiton 2021-02-12 1,260,625 $0.00 1,260,625 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,209,940 No 4 A Direct
1,476,659 No 4 A Direct
1,043,854 No 4 A Indirect
1,260,625 No 4 A Indirect
Footnotes
  1. These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC.
  2. These securities were purchased through the Issuer's directed share program in connection with its initial public offering.
  3. The LLC Units service-vest 6.25% on each three-month anniversary of May 9, 2018 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.
  4. The LLC Units vested 25% on January 1, 2020 and vest in equal monthly installments for three years thereafter. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.
  5. The LLC Units are fully vested and may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.
  6. The reporting person serves as sole manager of the LLCs, the membership interests of which are held through family trusts, the beneficiaries of which are the reporting person or his immediate family members.